Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients

Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients

US Patent 5785966 · Granted Jul 28, 1998

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and systems for scalable direct recycling of battery waste2025
Binding agents targeting TROP2-expressing tumor cells2025
Binding agents targeting TROP2-expressing tumor cells2025
Systems and methods for the recycling of lithium from battery waste2025
Tri-specific binding molecules2025
Binding agents targeting TROP2-expressing tumor cells2025
Systems and methods for removal and recycling of aluminum impurities from batter2025
Methods and systems for scalable direct recycling of battery waste2025
Systems and methods for the recycling of lithium from battery waste2024
Methods and systems for scalable direct recycling of batteries2024
Methods and systems for smart battery collection, sorting, and packaging2023
Methods and systems for scalable direct recycling of batteries2023